Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial-Reference-Cited by-同舟云学术

Ticagrelor monotherapy versus aspirin monotherapy at 12 months after percutaneous coronary intervention: a landmark analysis of the GLOBAL LEADERS trial

Published:2022-08 Issue:5 Volume:18 Page:e377-e388
ISSN:1969-6213
Container-title:EuroIntervention
language:
Short-container-title:

Author:

Ono Masafumi,Hara Hironori,Kawashima Hideyuki,Gao Chao,Wang Rutao,Wykrzykowska Joanna J.,Piek Jan J.,Garg Scot,Hamm Christian,Steg Philippe Gabriel,Valgimigli Marco,Windecker Stephan,Vranckx Pascal,Onuma Yoshinobu,Serruys Patrick Serruys

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. 2018 ESC/EACTS Guidelines on myocardial revascularization

2. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

3. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery

4. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

5. Ticagrelor with or without Aspirin in High-Risk Patients after PCI

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 ESC Guidelines for the management of chronic coronary syndromes;European Heart Journal;2024-08-30

2. Antiplatelet monotherapy after DAPT: is clopidogrel the new standard? Pros and cons;EuroIntervention;2024-06

3. Monotherapy with P2Y12-inhibitors after dual antiplatelet therapy: Filling gaps in evidence;International Journal of Cardiology;2024-04

4. Aspirin-free antiplatelet strategies after percutaneous coronary interventions;European Heart Journal;2024-01-18

5. Reply;Journal of the American College of Cardiology;2024-01